• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-101-3p 通过靶向甲状腺眼病中的 pentraxin-3 抑制眼眶成纤维细胞的增殖。

miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease.

机构信息

Department of Ophthalmology, Changzheng Hospital of Naval Medical University, Shanghai, China.

出版信息

PeerJ. 2024 Nov 15;12:e18535. doi: 10.7717/peerj.18535. eCollection 2024.

DOI:10.7717/peerj.18535
PMID:39559327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11572358/
Abstract

BACKGROUND

Excessive proliferation of orbital fibroblasts (OFs) is an essential factor in the pathogenesis of thyroid eye disease (TED). While existing evidence indicates that various microRNAs (miRNAs) significantly contribute to TED development, the precise function and targets of miR-101-3p in TED pathogenesis remain unknown. This research aims to elucidate the effects of miR-101-3p on TED-OFs and identify its potential targets.

METHODS

Orbital adipose tissues were harvested from both TED patients and healthy controls to culture their fibroblasts. MiR-101-3p mimic or mimic negative control (mimic NC) was transfected into OFs from TED patients, with untreated OFs serving as an additional blank control group. Cell proliferation was assessed using cell counting kit-8 (CCK-8) assay, Ki-67 immunofluorescence staining, and the EdU assay, while apoptosis was evaluated flow cytometry. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to measure the expression levels of miR-101-3p and pentraxin-3 (PTX3), and PTX3 protein levels were quantified using western blot. A dual-luciferase assay was conducted to ascertain how miR-101-3p and PTX3 interacted.

RESULTS

The results demonstrated a significant downregulation of miR-101-3p in fibroblasts and TED orbital adipose tissues. Transfection with the miR-101-3p mimic upregulated miR-101-3p levels, significantly reducing OFs proliferation without affecting apoptosis. Overexpression of miR-101-3p led to the downregulation of PTX3 in OFs. The dual-luciferase assay validated miR-101-3p binding to PTX3's 3'UTR, thereby repressing its expression. Moreover, overexpression of PTX3 partially rescued the miR-101-3p mimic's inhibitory effect on TED-OFs proliferation.

CONCLUSION

Our findings illustrate miR-101-3p's role in targeting PTX3 to regulate TED-OFs proliferation, providing novel insights into the pathological mechanisms underlying TED development.

摘要

背景

眼眶成纤维细胞(OFs)的过度增殖是甲状腺眼病(TED)发病机制的一个重要因素。虽然现有证据表明,各种 microRNAs(miRNAs)对 TED 的发展有重要贡献,但 miR-101-3p 在 TED 发病机制中的确切功能和靶标仍不清楚。本研究旨在阐明 miR-101-3p 对 TED-OFs 的影响,并鉴定其潜在的靶标。

方法

从 TED 患者和健康对照者的眼眶脂肪组织中提取眼眶脂肪组织,培养其成纤维细胞。将 miR-101-3p 模拟物或模拟物阴性对照(mimic NC)转染入 TED 患者的 OFs 中,未处理的 OFs 作为空白对照组。通过细胞计数试剂盒-8(CCK-8)检测、Ki-67 免疫荧光染色和 EdU 检测评估细胞增殖,通过流式细胞术评估细胞凋亡。采用定量实时聚合酶链反应(qRT-PCR)检测 miR-101-3p 和 pentraxin-3(PTX3)的表达水平,并用 Western blot 检测 PTX3 蛋白水平。通过双荧光素酶报告基因实验确定 miR-101-3p 和 PTX3 之间的相互作用方式。

结果

结果表明,成纤维细胞和 TED 眼眶脂肪组织中 miR-101-3p 的表达显著下调。转染 miR-101-3p 模拟物上调 miR-101-3p 水平,显著降低 OFs 增殖而不影响细胞凋亡。miR-101-3p 的过表达导致 OFs 中 PTX3 的下调。双荧光素酶报告基因实验验证了 miR-101-3p 与 PTX3 3'UTR 的结合,从而抑制其表达。此外,PTX3 的过表达部分挽救了 miR-101-3p 模拟物对 TED-OFs 增殖的抑制作用。

结论

我们的研究结果表明,miR-101-3p 通过靶向 PTX3 来调节 TED-OFs 的增殖,为 TED 发病机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/9e6e42052652/peerj-12-18535-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/41656fa421dd/peerj-12-18535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/6ea0e91be655/peerj-12-18535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/dace5af709cb/peerj-12-18535-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/9d8ba71e5db2/peerj-12-18535-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/9e6e42052652/peerj-12-18535-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/41656fa421dd/peerj-12-18535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/6ea0e91be655/peerj-12-18535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/dace5af709cb/peerj-12-18535-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/9d8ba71e5db2/peerj-12-18535-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1de9/11572358/9e6e42052652/peerj-12-18535-g005.jpg

相似文献

1
miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease.miR-101-3p 通过靶向甲状腺眼病中的 pentraxin-3 抑制眼眶成纤维细胞的增殖。
PeerJ. 2024 Nov 15;12:e18535. doi: 10.7717/peerj.18535. eCollection 2024.
2
TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.TSHR 信号通过 PI3K/Akt 诱导 miR-146a 和 miR-155 的表达促进甲状腺眼病眼眶成纤维细胞的增殖。
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4336-4345. doi: 10.1167/iovs.19-27865.
3
The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.miR-103a-3p/TGFBR3 轴调控甲状腺眼病中 TGF-β诱导的眼眶成纤维细胞活化和纤维化。
Mol Cell Endocrinol. 2023 Jan 1;559:111780. doi: 10.1016/j.mce.2022.111780. Epub 2022 Sep 27.
4
LncRNA LPAL2/miR-1287-5p/EGFR Axis Modulates TED-Derived Orbital Fibroblast Activation Through Cell Adhesion Factors.长链非编码RNA LPAL2/微小RNA-1287-5p/表皮生长因子受体轴通过细胞黏附因子调节甲状腺相关眼病来源的眼眶成纤维细胞活化。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2866-e2886. doi: 10.1210/clinem/dgab256.
5
Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts.甲状腺相关性眼病活动期患者血浆外泌体可诱导眼眶成纤维细胞炎症和纤维化。
J Transl Med. 2024 Jun 7;22(1):546. doi: 10.1186/s12967-024-05263-y.
6
Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.氯喹和羟氯喹通过靶向眼眶成纤维细胞在格雷夫斯眼眶病治疗中的新作用
J Clin Endocrinol Metab. 2020 Jun 1;105(6):1906-17. doi: 10.1210/clinem/dgaa161.
7
SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK/ERK1/2 Pathway.SOX9 通过 MAPK/ERK1/2 通路诱导甲状腺眼病中的眼眶成纤维细胞活化。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):25. doi: 10.1167/iovs.65.2.25.
8
Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy.他扎罗汀,一种芳烃受体配体,可减轻甲状腺眼病成纤维细胞的活化:对新型治疗方法的启示。
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):40. doi: 10.1167/iovs.65.13.40.
9
Pentraxin 3 mediates inflammation and adipogenesis in Graves' orbitopathy pathogenesis.Pentraxin 3 在格雷夫斯眼病发病机制中介导炎症和脂肪生成。
J Mol Endocrinol. 2024 Oct 14;73(4). doi: 10.1530/JME-24-0039. Print 2024 Nov 1.
10
MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK.微小 RNA-130a 在甲状腺眼病中升高,并通过抑制 AMPK 增加成纤维细胞中的脂质积累。
Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):29. doi: 10.1167/iovs.62.1.29.

引用本文的文献

1
Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy.靶向递送CD34适配体偶联的托珠单抗微球用于有效治疗甲状腺相关眼病
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):57. doi: 10.1167/iovs.66.11.57.

本文引用的文献

1
Oxidative modification of miR-30c promotes cardiac fibroblast proliferation via CDKN2C mismatch.氧化修饰的 miR-30c 通过 CDKN2C 错配促进心肌成纤维细胞增殖。
Sci Rep. 2024 Jun 7;14(1):13085. doi: 10.1038/s41598-024-63635-2.
2
LncRNA XIST promotes neovascularization in diabetic retinopathy by regulating miR-101-3p/VEGFA.长链非编码 RNA XIST 通过调控 miR-101-3p/VEGFA 促进糖尿病视网膜病变新生血管形成。
Arch Endocrinol Metab. 2024 May 10;68:e230097. doi: 10.20945/2359-4292-2023-0097.
3
MicroRNA-671-5p regulates the inflammatory response of periodontal ligament stem cells via the DUSP8/p38 MAPK pathway.
微小 RNA-671-5p 通过 DUSP8/p38 MAPK 通路调节牙周膜干细胞的炎症反应。
Mol Biol Rep. 2024 May 10;51(1):644. doi: 10.1007/s11033-024-09510-9.
4
Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells.氧化应激通过调节肝星状细胞中的 microRNA-144 和 SIN3A-p38 通路促进肝纤维化。
Int J Biol Sci. 2024 Apr 8;20(7):2422-2439. doi: 10.7150/ijbs.92749. eCollection 2024.
5
Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2.骨髄间充质干细胞来源的外泌体 miR-101-3p 通过调控 EZH2 水平促进非小细胞肺癌放射敏感性及对 DNA 损伤修复和自噬的影响
Pathol Res Pract. 2024 Apr;256:155271. doi: 10.1016/j.prp.2024.155271. Epub 2024 Mar 28.
6
MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.miR-21a-5p 通过靶向 STAT3 信号通路缓解系统性硬化症。
J Transl Med. 2024 Apr 1;22(1):323. doi: 10.1186/s12967-024-05056-3.
7
miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism.miR-101-3p介导的PDZK1在肝细胞癌进展中的作用及潜在的PI3K/Akt信号机制。
Cell Div. 2024 Mar 26;19(1):9. doi: 10.1186/s13008-023-00106-6.
8
Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention.黑色素瘤中miR-101-3p的缺失可稳定基因组完整性,从而防止细胞死亡。
Cell Mol Biol Lett. 2024 Mar 2;29(1):29. doi: 10.1186/s11658-024-00552-2.
9
Trials and Tribulations of MicroRNA Therapeutics.miRNA 治疗的困境与挑战
Int J Mol Sci. 2024 Jan 25;25(3):1469. doi: 10.3390/ijms25031469.
10
Interaction of estradiol and renin-angiotensin system with microRNAs-21 and -29 in renal fibrosis: focus on TGF-β/smad signaling pathway.雌激素与肾素-血管紧张素系统与 microRNAs-21 和 -29 在肾纤维化中的相互作用:聚焦于 TGF-β/smad 信号通路。
Mol Biol Rep. 2024 Jan 18;51(1):137. doi: 10.1007/s11033-023-09127-4.